Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...